LISA LEWIS: Open Payments
NPI 1255982906 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 58 payments from 11 companies in 2025. Trend: 2023 $563 · 2024 $626 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $247 |
| Novo Nordisk Inc | 6 | $198 |
| ABBVIE INC. | 15 | $193 |
| PFIZER INC. | 16 | $189 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| Corcept Therapeutics | 2 | $42 |
| Lilly USA, LLC | 2 | $37 |
| Exact Sciences Corporation | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 2 | $32 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $25 |
Products named: AIRSUPRA, Ozempic, NURTEC ODT, VRAYLAR, Kerendia, QULIPTA, Korlym, UBRELVY.
Industry payments across VA — which companies pay providers there.
